SPOTLIGHT: FDA plans to issue more early warnings


The FDA is planning to get a lot more aggressive about communicating with consumers about side effects generated by drugs already on the market. The agency's leaders say they're taking this step because they're able to find more of such effects in drugs already on the market, using the money and authority got from last year's FDA reform and funding law. FiercePharma

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.